Business

Figures converted from INR at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, and multiples are unitless and unchanged.

Know the Business — Olectra Greentech

Bottom line. Olectra is a manufacturer-financier hybrid: it builds an electric bus, sells it to a captive Special Purpose Vehicle (SPV) it part-owns, then collects 12 years of per-kilometre revenue from a State Road Transport Undertaking (STU) backstopped by a central subsidy. That structure makes returns on capital, working-capital cycles, and counterparty risk look more like an infrastructure operator than a passenger-car OEM. The market is pricing it like a high-multiple growth manufacturer (~73× trailing P/E, ~10× book) on a 14% EBITDA margin and ~14% ROE — the question is not whether the order book is big but whether the subsidy-and-tender chain pays on time and whether localisation outruns BYD-dependence.

1. How This Business Actually Works

Olectra has two unrelated businesses, but ~91% of FY25 revenue comes from one of them, and that one has unusual mechanics: the customer pays per kilometre, not per bus.

The economic engine in five steps.

Where the money is. The OEM-level EBITDA pool (manufacturing + AMC) runs 13–15% today, with management guiding to 10–12% long-term as 9m and truck volumes scale and product mix dilutes the 12m premium. The richer pool sits in the SPV (>15% IRR over 12 years) and the central subsidy (~$0.25/km × ~280 km/day × 12 years ≈ $13K/bus/year of subsidised income for the operator). Composite polymer insulators is a small but high-margin annuity — ~$26–32M revenue at 25–30% segment EBITDA, with 40% of sales exported.

What constrains incremental profit. Bottleneck #1 is not factory capacity (Seetharampur Phase-I gives 5,000 buses/year on double shift, well above the FY26 guide of 1,500–2,000); it is STU depot readiness, electricity grid connections, and SPV financing closure. The Q3 FY26 transcript is unusually clear on this: management cites a competitor with "600 buses waiting six months in Delhi for deployment" — $79–85M of stranded inventory — and explicitly says they will not push beyond what the market can absorb. Bottleneck #2 is counterparty payment timing: when STUs delay, working capital balloons, ICRA notches the rating, and the SPV's ability to raise debt for the next tender narrows.

Bargaining power is asymmetric. Olectra has pricing power on the OEM bus (the tender L1 sets the price, but only 4–5 OEMs have localisation depth and SPV-equity capacity to bid). It has almost none on the BoM (battery, motor, controller are imported or BYD-licensed) and none on the per-km tariff once the GCC is signed. The BEST Mumbai dispute (live in Q3 FY26) — buses carrying 102 passengers vs. 58 specified, prompting renegotiation — is the textbook case of how pricing power evaporates after contract signature.

2. The Playing Field

Olectra is the largest pure-play e-bus listing but a small fish next to the diversified CV majors that are sliding into EVs. The peer set is mixed by design — direct e-bus rivals (JBM, Switch via Ashok Leyland) plus the diversified ICE bus benchmarks (Eicher, Force) and the insulator overlap (Apar).

What the peer set reveals.

• Olectra trades at the highest growth-stock multiple in the room (73× TTM P/E, ~10× book) on the second-lowest ROCE. That gap is the entire investment debate. The market is paying for trajectory — ~3× revenue from FY22 to FY25 (₹593 cr → ₹1,802 cr), the steepest in the peer set — not for current capital efficiency.
• The "good business" benchmarks are Eicher, Force and Apar, not the e-bus peers. Each runs 30%+ ROCE on diversified product mix and pays dividends. JBM is the only peer with comparable economics and it trades at a similar multiple — both are "the EV bus story" in listed Indian markets.
• Ashok Leyland is the most under-discussed competitor. It is 10× Olectra's market cap, runs higher op margin (19%) at lower P/E (28×), and through Switch Mobility is a direct e-bus rival with deeper distribution. If the e-bus market commoditises, Ashok Leyland's diversified base is a far better cushion than Olectra's pure-play exposure.
• JBM Auto is the cleanest "fair comparison." Same focus, similar size, same multiple, similar ROE — but lower ROCE because of higher capital intensity. Watching JBM's order conversion vs. Olectra's quarter-by-quarter is the best read on whether either has structural advantage.
• Apar is on the table only because of the insulator overlap (~9% of Olectra revenue). It runs the segment at scale (~$2.3B revenue) with ROCE > 30%; Olectra's insulator unit is a footnote next to Apar's full-stack T&D play.

3. Is This Business Cyclical?

Yes — but the cycle is policy-and-tender, not consumer-demand. Diesel-bus replacement is a slow tailwind; what actually swings the printer is central tender flow, subsidy disbursement velocity, and STU payment timing. The classic auto cyclicals (commodity prices, festival demand, dealer days) are largely background noise here.

Where the cycle hits.

• Working capital and DSO — the first indicator. FY2020's 658 debtor days was the original SPV-financing crunch; the ~140 today reflects PM e-Bus Sewa disbursement working as designed. A move back above 180 days is the canary.
• Order intake (tender flow) — episodic, not seasonal. PM E-DRIVE 10,900-bus tender (FY26) and the upcoming CESL 3,000+ bus tender for Mumbai/Pune/Hyderabad are the next two pulses. A six-month tender drought would compress visibility but leave the existing 9,400-bus order book to convert.
• Counterparty repricing — the BEST Mumbai overload dispute (Q3 FY26: 102 passengers vs. 58 spec) is the live case study of how a contract written at 2022 unit economics goes off-rails when usage diverges. Maharashtra's earlier ~$1.06B cancellation episode (the stock fell 14% on the news) is the same risk in tender form.
• Margin volatility from product mix, not from input cost. Q3 FY26 EBITDA at 14.1% looked compressed vs. peer expectations because the 9m / truck mix dilutes the 12m premium — that is mix, not margin pressure.

The cycle that is not this business: passenger replacement demand. STU diesel buses retire on a 15–20 year cycle; nothing about the consumer makes deliveries lumpy.

4. The Metrics That Actually Matter

The conventional auto KPIs (volumes, ASP, dealer inventory) are partly useful here but miss the project-finance overlay. The right scorecard combines manufacturing, working-capital, and policy metrics.

The metric most often misread. Per-bus realisation (revenue ÷ units) falls when 9m city buses, intercity coaches, and trucks are added to the mix. That looks like ASP compression but it is product-line broadening. Watch per-bus EBITDA in absolute dollars and EV-segment EBITDA% adjusted for mix, not blended ASP, to see real operating leverage. Likewise, headline P/E is misleading on a captive-SPV system because the real economic asset (the 12-year per-km revenue stream) sits at the associate level, not on Olectra's P&L.

5. What Is This Business Worth?

The company is best valued as one economic engine right now (the EV segment dominates), but a serious investor should also look at it as two-plus-one parts: the OEM, the captive SPV portfolio, and the insulator annuity. The OEM's earnings power is observable; the SPV portfolio's value is not yet visible in consolidated GAAP because Evey Trans is an associate (equity-method) and the per-km revenue stream lives off-balance-sheet.

The one sentence on what determines value. Value here is forward earnings power on a normalised EBITDA margin (10–12%) at a believable run-rate (3,000–5,000 buses/year), plus whatever the captive SPV concession portfolio is worth as an infrastructure asset over 12 years, minus a discount for tender-flow lumpiness, BYD-tech dependence, and STU payment-timing risk.

On SOTP. A formal sum-of-the-parts is tempting given the captive SPV cluster, but the data is not there to do it cleanly. The associate SPVs are not separately listed; per-km tariffs and depreciation/financing schedules are not disclosed at the project level; and any value Olectra holds at 1–26% of an SPV is gated by exit mechanics that have not been tested. The right way to use SOTP today is as a sense-check, not a target: if the OEM is worth ~$634–846M at industry-normalised multiples and insulators are worth ~$53–85M at peer-level EV/EBITDA, the residual ~$210–425M of market cap is what the market is paying for SPV optionality plus growth runway. Whether that residual is cheap or expensive depends entirely on whether the next two tenders deliver and whether STUs pay on time.

6. What I'd Tell a Young Analyst

Don't read this as an auto OEM. The right mental model is "captive infrastructure operator that happens to sell buses." The order book matters less than the conversion rate of that order book; the EBITDA margin matters less than absolute $/bus EBITDA at constant mix; and the consolidated balance sheet matters less than what is happening at Evey Trans Pvt Ltd. Three things would change the view, in order.

1. Working capital backsliding. If DSO rises back through 180 days for two consecutive quarters, ICRA action will follow and SPV financing for the next tender narrows. That is the only metric I check first every quarter.
2. Localisation milestones. Battery cell-pack and motor-controller domestic content moving toward PLI thresholds is the single biggest tail-risk reducer. Without it, BYD geopolitics is a permanent overhang and the 73× P/E is hard to defend.
3. Order conversion, not order book. Q3 FY26: 9,400 unshipped, 385 delivered. Watching the L1-to-LoA-to-delivery ratio over the next four quarters tells you more about FY27 earnings than any guidance. If 1,785 PM E-DRIVE buses convert cleanly, the run-rate doubles; if they slip on depot readiness, the order book becomes a paper asset.

What the market is most likely getting wrong. It is paying for OEM-style operating leverage on a business whose real economic asset is a 12-year project-finance receivable stream that does not show up cleanly on the P&L. That cuts both ways: bullish if SPV IRRs hold and the cluster ever crystallises (sale, IRR transparency, or partial listing); bearish if STU payment delays or contract renegotiations propagate. The thesis is not "Will Olectra deliver buses?" — they will. It is "Will the per-km cash flow chain stay clean enough to fund the next decade of tenders?" Spend your time on subsidy disbursement velocity and SPV financing windows, not on monthly VAHAN registrations.